2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity

被引：5

作者：

Antonopoulou, Georgia ^{[1
,4
]}

Magrioti, Victoria ^{[1
]}

Kokotou, Maroula G. ^{[1
]}

Nikolaou, Aikaterini ^{[1
]}

Barbayianni, Efrosini ^{[1
]}

Mouchlis, Varnavas D. ^{[2
,3
]}

Dennis, Edward A. ^{[2
,3
]}

Kokotos, George ^{[1
]}

机构：

[1] Univ Athens, Dept Chem, Athens 15771, Greece

[2] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, MC 0601, La Jolla, CA 92093 USA

[3] Univ Calif San Diego, Sch Med, Dept Pharmacol, MC 0601, La Jolla, CA 92093 USA

[4] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 19期

关键词：

GIVA cPLA(2); Inhibitors; Lipophilicity; 2-Oxoamides; Phospholipase A(2); IN-VITRO; PYRROLIDINE INHIBITORS; METABOLIC STABILITY; BIOLOGICAL-ACTIVITY; AMINO-ACIDS; A(2)ALPHA; DISCOVERY; POTENT; SERIES; 1-INDOL-1-YL-PROPAN-2-ONES;

D O I：

10.1016/j.bmc.2016.07.057

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity. We have developed a variety of long chain 2-oxoamides as inhibitors of GIVA PLA(2). Among them, AX048 was found to produce a potent analgesic effect. We have now reduced the lipophilicity of AX048 by replacing the long aliphatic chain with a chain containing an ether linked aromatic ring with in vitro inhibitory activities similar to AX048. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：4544 / 4554

页数：11

共 50 条

[1] Novel 2-oxoamide inhibitors of human group IVA phospholipase A2
Kokotos, G
Kotsovolou, S
Six, DA
Constantinou-Kokotou, V
Beltzner, CC
Dennis, EA
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) : 2891 - 2893
[2] Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group v secreted phospholipase A2
Six, David A.
Barbayianni, Efrosini
Loukas, Vassilios
Constantinou-Kokotou, Violetta
Hadjipavlou-Litina, Dimitra
Stephens, Daren
Wong, Alan C.
Magrioti, Victoria
Moutevelis-Minakakis, Panagiota
Baker, Sharon F.
Dennis, Edward A.
Kokotos, George
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 4222 - 4235
[3] Binding Conformation of 2-Oxoamide Inhibitors to Group IVA Cytosolic Phospholipase A2 Determined by Molecular Docking Combined with Molecular Dynamics
Mouchlis, Varnavas D.
Michopoulou, Vasiliki
Constantinou-Kokotou, Violetta
Mavromoustakos, Thomas
Dennis, Edward A.
Kokotos, George
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (01) : 243 - 254
[4] 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides
Barbayianni, Efrosini
Stephens, Daren
Grkovich, Andrej
Magrioti, Victoria
Hsu, Yuan-Hao
Dolatzas, Panagiotis
Kalogiannidis, Dimitrios
Dennis, Edward A.
Kokotos, George
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (13) : 4833 - 4843
[5] Mechanism of group IVA cytosolic phospholipase A2 activation by phosphorylation
Das, S
Rafter, JD
Kim, KP
Gygi, SP
Cho, WH
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 41431 - 41442
[6] 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
Kokotou, Maroula G.
Galiatsatou, Gerasimia
Magrioti, Victoria
Koutoulogenis, Giorgos
Barbayianni, Efrosini
Limnios, Dimitris
Mouchlis, Varnavas D.
Satpathy, Banita
Navratil, Aaron
Dennis, Edward A.
Kokotos, George
SCIENTIFIC REPORTS, 2017, 7
[7] 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
Maroula G. Kokotou
Gerasimia Galiatsatou
Victoria Magrioti
Giorgos Koutoulogenis
Efrosini Barbayianni
Dimitris Limnios
Varnavas D. Mouchlis
Banita Satpathy
Aaron Navratil
Edward A. Dennis
George Kokotos
Scientific Reports, 7
[8] Overexpression and regulation of cytosolic phospholipase A2 group IVA in patients with asthma
Sokolowska, M.
Stefanska, J.
Luczak, E.
Wodz-Naskiewicz, K.
Cieslak, M.
Pawliczak, R.
ALLERGY, 2010, 65 : 2 - 3
[9] Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A2α Inhibitors
Chen, Lihren
Wang, Weiheng
Lee, Katherine L.
Shen, Marina W. H.
Murphy, Elizabeth A.
Zhang, Wen
Xu, Xin
Tam, Steve
Nickerson-Nutter, Cheryl
Goodwin, Debra G.
Clark, James D.
McKew, John C.
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (04) : 1156 - 1171
[10] Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases
Barbayianni, Efrosini
Antonopoulou, Georgia
Kokotos, George
PURE AND APPLIED CHEMISTRY, 2012, 84 (09) : 1877 - 1894

← 1 2 3 4 5 →